1. Home
  2. CVU vs KLRS Comparison

CVU vs KLRS Comparison

Compare CVU & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Aerostructures Inc.

CVU

CPI Aerostructures Inc.

HOLD

Current Price

$2.89

Market Cap

44.5M

Sector

Industrials

ML Signal

HOLD

Logo Kalaris Therapeutics Inc. Common Stock

KLRS

Kalaris Therapeutics Inc. Common Stock

HOLD

Current Price

$5.49

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVU
KLRS
Founded
1980
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
46.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CVU
KLRS
Price
$2.89
$5.49
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.50
AVG Volume (30 Days)
205.0K
160.4K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$71,616,326.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$2.14
52 Week High
$5.85
$12.90

Technical Indicators

Market Signals
Indicator
CVU
KLRS
Relative Strength Index (RSI) 62.87 48.34
Support Level $2.69 $5.10
Resistance Level $2.89 $7.07
Average True Range (ATR) 0.19 0.68
MACD 0.05 -0.09
Stochastic Oscillator 88.54 29.52

Price Performance

Historical Comparison
CVU
KLRS

About CVU CPI Aerostructures Inc.

CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter, and others.

About KLRS Kalaris Therapeutics Inc. Common Stock

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

Share on Social Networks: